首页> 美国卫生研究院文献>BioMed Research International >Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis
【2h】

Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis

机译:基于结构的虚拟筛选和分子动力学分析从中药中鉴定有效的氯化物细胞内通道蛋白1抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chloride intracellular channel 1 (CLIC1) is involved in the development of most aggressive human tumors, including gastric, colon, lung, liver, and glioblastoma cancers. It has become an attractive new therapeutic target for several types of cancer. In this work, we aim to identify natural products as potent CLIC1 inhibitors from Traditional Chinese Medicine (TCM) database using structure-based virtual screening and molecular dynamics (MD) simulation. First, structure-based docking was employed to screen the refined TCM database and the top 500 TCM compounds were obtained and reranked by X-Score. Then, 30 potent hits were achieved from the top 500 TCM compounds using cluster and ligand-protein interaction analysis. Finally, MD simulation was employed to validate the stability of interactions between each hit and CLIC1 protein from docking simulation, and Molecular Mechanics/Generalized Born Surface Area (MM-GBSA) analysis was used to refine the virtual hits. Six TCM compounds with top MM-GBSA scores and ideal-binding models were confirmed as the final hits. Our study provides information about the interaction between TCM compounds and CLIC1 protein, which may be helpful for further experimental investigations. In addition, the top 6 natural products structural scaffolds could serve as building blocks in designing drug-like molecules for CLIC1 inhibition.
机译:氯化物细胞内通道1(CLIC1)参与了大多数侵袭性人类肿瘤的发展,包括胃癌,结肠癌,肺癌,肝癌和胶质母细胞瘤。它已成为多种类型癌症的有吸引力的新治疗靶标。在这项工作中,我们旨在使用基于结构的虚拟筛选和分子动力学(MD)模拟,从中药(TCM)数据库中鉴定天然产物作为有效的CLIC1抑制剂。首先,基于结构的对接被用于筛选精炼的TCM数据库,并获得了前500种TCM化合物并通过X-Score进行排名。然后,使用聚类和配体-蛋白质相互作用分析,从排名前500位的中药化合物中获得30个有效命中率。最后,通过对接模拟,采用MD模拟来验证每个命中与CLIC1蛋白之间相互作用的稳定性,并使用分子力学/广义生表面积(MM-GBSA)分析来完善虚拟命中。六个具有MM-GBSA最高分和理想结合模型的TCM化合物被确认为最终命中。我们的研究提供了有关中药化合物与CLIC1蛋白之间相互作用的信息,这可能有助于进一步的实验研究。此外,排名前6位的天然产物结构支架可作为设计抑制CLIC1的类药物分子的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号